Bayer | BAYN

Stock Price
28.16
Daily Change
-0.42 -1.47%
Monthly
10.98%
Yearly
-1.83%
Q3 Forecast
27.94

Peers Price Chg Day Year Date
Covestro 55.30 -1.00 -1.78% 0.04% Sep/05
Air Liquide 175.38 -0.82 -0.47% 5.52% Sep/06
Arkema 57.35 0.05 0.09% -27.45% Sep/05
Akzo Nobel 60.36 1.26 2.13% 3.71% Sep/06
Alcon AG 64.08 0.62 0.98% -19.15% Sep/05
Amarin 15.33 0.30 2.00% 27.64% Sep/05
AstraZeneca 12,090.00 -98.00 -0.80% -4.89% Sep/06
BASF 43.81 -0.19 -0.43% 0.53% Sep/06
Bayer 28.16 -0.42 -1.47% -1.83% Sep/06
Beiersdorf 97.32 -1.58 -1.60% -23.97% Sep/06
Corteva 72.30 -0.35 -0.48% 30.67% Sep/05
Vinci 115.55 -0.35 -0.30% 5.24% Sep/06
Essilor 259.60 -0.60 -0.23% 22.74% Sep/06
Fresenius Medical Care 41.99 0.28 0.67% 16.83% Sep/06
Fresenius 46.82 -0.36 -0.76% 39.22% Sep/06
Genmab 1,751.50 6.50 0.37% -5.83% Sep/05
Givaudan 3,504.00 21.00 0.60% -20.53% Sep/05
GRIFOLS 12.30 0.02 0.16% 32.17% Sep/05
GlaxoSmithKline 1,476.00 7.00 0.48% -10.63% Sep/05
Henkel 74.08 0.20 0.27% -8.45% Sep/06
Hikma Pharmaceutical 1,720.00 -3.00 -0.17% -12.07% Sep/05
Johnson Matthey 1,919.00 1.00 0.05% 22.62% Sep/05
Linde 398.60 -5.80 -1.43% -3.63% Sep/05
Lonza 577.40 -0.80 -0.14% 7.68% Sep/05
Merck 109.55 1.05 0.97% -35.52% Sep/06
Novartis 103.98 0.06 0.06% 5.46% Sep/05
Nutrien 78.16 -0.63 -0.80% 24.38% Sep/05
Philips 23.80 0.02 0.08% -12.63% Sep/06
PPG Industries 109.98 0.34 0.31% -11.90% Sep/05
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Sanofi 79.50 0.54 0.68% -24.83% Sep/06
SAP 228.25 -4.95 -2.12% 18.52% Sep/06
Solvay 27.48 0.18 0.66% -11.95% Sep/05
UCB 206.90 2.30 1.12% 28.99% Sep/05
Umicore 13.31 0.07 0.53% 31.13% Sep/05

Indexes Price Day Year Date
EU50 5318 -28.56 -0.53% 12.24% Sep/05
DE40 23597 -173.35 -0.73% 28.93% Sep/05
EU600 549 -0.88 -0.16% 8.42% Sep/05

Bayer traded at 28.16 this Saturday September 6th, decreasing 0.42 or 1.47 percent since the previous trading session. Looking back, over the last four weeks, Bayer lost 10.98 percent. Over the last 12 months, its price fell by 1.83 percent. Looking ahead, we forecast Bayer to be priced at 27.94 by the end of this quarter and at 27.29 in one year, according to Trading Economics global macro models projections and analysts expectations.

Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non